Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of chronic pain following a shingles infection.

Phase 2

Pfizer